60 filings
8-K
ALLO
Allogene Therapeutics Inc
14 Mar 24
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023
4:10pm
8-K
ALLO
Allogene Therapeutics Inc
16 Feb 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:30am
8-K
ALLO
Allogene Therapeutics Inc
31 Jan 24
Entry into a Material Definitive Agreement
12:00am
8-K
ALLO
Allogene Therapeutics Inc
5 Jan 24
Entry into a Material Definitive Agreement
8:00am
8-K
ALLO
Allogene Therapeutics Inc
19 Dec 23
Other Events
3:46pm
8-K
vpjpk
2 Nov 23
Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
4:03pm
8-K/A
2la ej959nnfccadv9
17 Oct 23
Departure of Directors or Certain Officers
4:34pm
8-K
suonvx4
16 Oct 23
Departure of Directors or Certain Officers
8:31am
8-K
dyw78
2 Aug 23
Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
4:04pm
8-K
ans35
21 Jun 23
Other Events
4:05pm
8-K
3l94lqfkpy4e1h
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
3lu ebhg60
14 Jun 23
Departure of Directors or Certain Officers
8:04am
8-K
uuxvekulrjl j1f9zn8d
7 Jun 23
Other Events
4:16pm
8-K
lhk kvhtd
3 May 23
Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update
4:05pm
8-K
v5fwdfkj yw5ik8sp66
20 Apr 23
Departure of Directors or Certain Officers
4:08pm
8-K
3gypddgpjf0b
10 Mar 23
Regulation FD Disclosure
4:00pm
8-K
4ptve92iys8
28 Feb 23
Allogene Therapeutics Reports Fourth Quarter and Full Year 2022
4:07pm
8-K
cpu4f mda4
3 Jan 23
Departure of Directors or Certain Officers
8:05am
8-K
e5rt903wm0aly
29 Nov 22
Other Events
3:33pm
8-K
54huncld9a1jnvrwht
2 Nov 22
Allogene Therapeutics Reports Third Quarter 2022 Financial Results and Announces Investor R&D Showcase
4:16pm